School of Medicine
Showing 121-130 of 130 Results
-
Jack Tzu-Chieh Wang
Instructor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsOur primary research focus is understanding the molecular mechanisms of axonal degeneration and subsequent failure of axonal regeneration in the CNS. We have identified critical cellular pathways mediating axonal degeneration following acute neurological injuries including ischemic stroke and traumatic brain injury. Modulating these pathways presents a novel therapeutic strategy to protect vulnerable nerve fibers and enhance functional recovery in a multitude of acute CNS injuries and diseases.
-
Edward N. Wilson
Instructor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsSingle-cell transcriptomic profiling of immune cells in Alzheimer's disease brain
Alzheimer's disease, Parkinson's disease and multiple sclerosis biomarkers
Alzheimer’s disease experimental therapeutics -
Kyan Younes, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Younes is a fellowship-trained, board-certified neurologist and a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
His areas of expertise include the diagnosis and treatment of Alzheimer’s disease, frontotemporal dementia, primary progressive aphasia, Lewy body dementia, normal pressure hydrocephalus and cognitive and behavioral impairments. For each patient, Dr. Younes develops a personalized plan of care. A plan may include his close collaboration with experts from psychiatry, nursing, pharmacy, genetic counseling, and other specialties. His goal is to ensure that each patient receives care that is both comprehensive and compassionate.
To help lead advances and innovations in his field, Dr. Younes conducts extensive research. He is studying the clinical, neuropsychological, socioemotional, genetic, and pathological features when a patient experiences degeneration of the right anterior temporal lobe area of the brain. This disorder can affect a person’s ability to process emotions and person-specific knowledge.
He also is researching how multimodal brain imaging, including magnetic resonance imaging (MRI) and Positron Emission Tomography (PET) combined with machine learning can help improve the detection of neurodegenerative diseases. In other research, he has participated in clinical trials of new drug therapies for Alzheimer’s disease.
Dr. Younes has presented research findings at meetings of the American Neurological Association, American Academy of Neurology, and American Psychiatric Association. Topics have included predictors of cognitive performance in dementia.
He has co-authored research articles published in the American Journal of Psychiatry, Annals of Clinical and Translational Neurology, Journal of Neuroimaging, and elsewhere. Subjects of these articles have included guidelines for diagnosing the effects of right anterior temporal lobe degeneration on behavior, treatment for symptoms of encephalitis, and the impact of mild traumatic brain injury on healthy older adults.
Dr. Younes has written chapters on frontotemporal dementia for Psychiatric Clinics as well as the epilepsy, coma, acute ischemic stroke, meningitis and encephalitis chapters for the textbook The Little Black Book of Neurology.
He is a member of the American Academy of Neurology, American Neurological Association, Alzheimer’s Association, and International Society for Frontotemporal Dementias. -
Christina Young
Instructor, Neurology & Neurological Sciences
BioDr. Christina Young obtained her PhD in Clinical Psychology as well as her MS in Statistics at Northwestern University. She completed her predoctoral internship at the University of Illinois Chicago where she specialized in neuropsychology. She continued her neuropsychology training as well as her research during her postdoctoral fellowship at Stanford University.
Dr. Young's research focuses on identifying real-world declines in cognition that track with the pathological changes in neurodegenerative disorders such as Alzheimer’s disease (AD) and related dementias. Her work incorporates novel measures of cognition as well as neuroimaging to improve the detection and monitoring of early cognitive decline in the context of AD and related dementias. She has been awarded grant funding through a K99/R00 from the NIH and an Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D) from the Alzheimer's Association. -
Hengameh Zahed, MD, PhD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Zahed is a board-certified, fellowship-trained neurologist with the Stanford Medicine Movement Disorders Center. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences.
She diagnoses and treats a wide range of movement disorders including Parkinson’s disease, Huntington’s disease, essential tremor, dystonia, and ataxia. She creates a personalized treatment plan for each of her patients using a variety of treatment options, including pharmacological and non-pharmacological options, deep brain stimulation (DBS) treatment for Parkinson's disease and tremors, and botulinum toxin injections for movement disorders and spasticity.
Prior to joining Stanford University, Dr. Zahed completed a neurology residency and fellowship in movement disorders at University of California, San Francisco (UCSF), where she also earned her MD and PhD in biomedical sciences. Dr. Zahed’s research interests include understanding the genetic and electrophysiological underpinnings of movement disorders and investigating applications of wearable technologies to monitor symptoms and improve the quality of life in patients with movement disorders. She also participates in clinical trials of new therapeutics for Parkinson’s disease and other movement disorders.
Dr. Zahed has published in Movement Disorders, Molecular Genetics & Genomic Medicine, The Journal of Clinical Investigation, American Journal of Human Genetics, Cell, and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings. These meetings have included the International Congress of Parkinson’s Disease and Movement Disorders, the Hereditary Disease Foundation Symposium, the World Society for Stereotactic and Functional Neurosurgery, and the Society for Neuroscience.
Dr. Zahed is a member of the International Parkinson and Movement Disorders Society. -
Fanglin Zhang, MD., PhD.
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Zhang is a board-certified, fellowship-trained neurologist. She serves as a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
Dr. Zhang diligently excels in diagnosing and treating complex neurological conditions. Her clinical interests span a broad spectrum, with a current emphasis on intractable epilepsy and urgent stroke care. With each patient, Dr. Zhang forms a strong alliance focused on overcoming neurological disease and improving quality of life. She practices a patient-centered and evidence-based medicine.
As a clinician educator, she finds joy in educating both patients and trainees. She also enjoys conducting cutting-edge clinical research. Her work has been published in numerous peer-reviewed journals, such as Neurological Sciences, Annals of Clinical and Translational Neurology, Neuroimage, Glia, Immunology, the Journal of Psychiatric Practice, Journal of Neuroimmunology, etc. Her current research interest includes clinical trials and a large cohort study of the impact of seizures on stroke outcomes.
Among her many honors, Dr. Zhang has won a grant award from the National Multiple Sclerosis Society. Dr. Zhang shows a great enthusiasm in public welfare. She has earned recognition for volunteering her time and expertise at family health centers, hospitals, and schools. -
Niushen Zhang
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.
Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.
